Review
doi: 10.1081/dmr-120001391.
Structure-activity relationship for human cytochrome P450 substrates and inhibitors
Affiliations
- PMID: 11996013
- DOI: 10.1081/dmr-120001391
Item in Clipboard
Review
Structure-activity relationship for human cytochrome P450 substrates and inhibitors
Drug Metab Rev.
2002 Feb-May.
Abstract
Criteria governing the avidity of substrate binding to human hepatic cytochromes P450 (CYP) associated with Phase 1 metabolism of drugs are described. The results of extensive quantitative structure-activity relationship (QSAR) analyses are reported for substrates of human P450s: CYPIA2, CYP2A6, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4, representing the enzymes exhibiting major involvement in the metabolism of drug substrates in Homo sapiens. In particular, it is shown that hydrogen bond properties in each class of enzyme-substrate complex are especially important factors in determining substrate binding affinity towards those human P450s which are involved in drug metabolism.
Similar articles
-
Molecular modeling of human cytochrome P450-substrate interactions.Drug Metab Rev. 2002 Feb-May;34(1-2):55-67. doi: 10.1081/dmr-120001390. Drug Metab Rev. 2002. PMID: 11996012 Review.
-
Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolism.Drug Metabol Drug Interact. 2001;18(3-4):221-42. doi: 10.1515/dmdi.2001.18.3-4.221. Drug Metabol Drug Interact. 2001. PMID: 11791886 Review.
-
On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism.Biochem Pharmacol. 2000 Aug 1;60(3):293-306. doi: 10.1016/s0006-2952(00)00335-x. Biochem Pharmacol. 2000. PMID: 10856424
-
Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity.Exp Toxicol Pathol. 1999 Jul;51(4-5):369-74. doi: 10.1016/S0940-2993(99)80024-4. Exp Toxicol Pathol. 1999. PMID: 10445400
-
Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes.Arch Biochem Biophys. 2003 Jan 1;409(1):32-44. doi: 10.1016/s0003-9861(02)00349-1. Arch Biochem Biophys. 2003. PMID: 12464242
Cited by
-
Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.Molecules. 2012 Aug 3;17(8):9283-305. doi: 10.3390/molecules17089283. Molecules. 2012. PMID: 22864238 Free PMC article. Review.
-
QSAR analysis of the inhibition of recombinant CYP 3A4 activity by structurally diverse compounds using a genetic algorithm-combined partial least squares method.Pharm Res. 2003 Sep;20(9):1401-8. doi: 10.1023/a:1025702009611. Pharm Res. 2003. PMID: 14567634
-
The Activation of Endothelial Cells Relies on a Ferroptosis-Like Mechanism: Novel Perspectives in Management of Angiogenesis and Cancer Therapy.Front Oncol. 2021 May 10;11:656229. doi: 10.3389/fonc.2021.656229. eCollection 2021. Front Oncol. 2021. PMID: 34041026 Free PMC article.
-
Effects of some commonly used Saudi folk herbal medications on the metabolic activity of CYP2C9 in human liver microsomes.Saudi Pharm J. 2010 Jul;18(3):167-71. doi: 10.1016/j.jsps.2010.05.008. Epub 2010 May 31. Saudi Pharm J. 2010. PMID: 23964176 Free PMC article.
-
Modeling kinetics of subcellular disposition of chemicals.Chem Rev. 2009 May;109(5):1793-899. doi: 10.1021/cr030440j. Chem Rev. 2009. PMID: 19265398 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
